1.
J Hematother Stem Cell Res
; 8(4): 331-2, 1999 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-10634169
2.
Haematologica
; 83(8): 763-5, 1998 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-9793271
RESUMO
Most therapies for elderly patients with myelodysplastic syndromes offer few short responses and little improvement in survival. We describe two patients who, after several cycles of low dose cytosine arabinoside and GM-CSF, achieved and maintained complete remission and became transfusion independent. Previous chromosomal abnormalities also disappeared and karyotype remains normal.